Pfizer has appointed Berta Rodriguez-Hervas as its chief artificial intelligence and analytics officer. This strategic move aims to enhance the company's digital leadership and strengthen its AI initiatives. Rodriguez-Hervas will also serve as co-chair of Pfizer's AI council, indicating a commitment to integrating AI into its operations.
The appointment reflects the growing importance of AI in the pharmaceutical industry, particularly in drug development and analytics. By bolstering its digital team, Pfizer is positioning itself to leverage AI technologies for improved decision-making and operational efficiency. This move is expected to drive innovation and enhance patient outcomes through data-driven insights.
• Berta Rodriguez-Hervas appointed as chief AI and analytics officer at Pfizer.
• Pfizer aims to enhance AI integration in its operations and decision-making.
AI is crucial for Pfizer's strategy to enhance drug development and analytics.
Analytics will play a key role in Pfizer's efforts to derive insights from large datasets.
The establishment of an AI council at Pfizer signifies a structured approach to AI governance.
Pfizer's recent appointment of a chief AI officer highlights its commitment to integrating AI into its business strategy.
Business Insider on MSN.com 7month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.